Stockreport

Valeant Announces Sale of iNova Pharmaceuticals for $930 Million

VALEANT PHARMACEUTICALS  (VRX) 
Last valeant pharmaceuticals earnings: 2/28 07:00 am Check Earnings Report
US:NYSE Investor Relations: ir.valeant.com
PDF LAVAL, Quebec, June 8, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced it has entered into an agree [Read more]